Zacks Investment Research on MSN
EU approves Novo Nordisk's higher-dose Wegovy for obesity patients
Novo Nordisk NVO announced that the European Commission (EC) has approved a new 7.2 mg once-weekly maintenance dose of Wegovy (semaglutide injection) for adults with obesity. This provides physicians ...
Wegovy jab users face regaining the weight they have lost, with patients finding themselves blocked from getting further prescriptions on the NHS. Some people attending hospital obesity clinics were ...
Millions of people use injectable drugs like Wegovy to reach a healthier weight. But the weekly injections aren't for everybody — or every wallet. That's why pills that could achieve similar results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results